ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Policy

Former Lilly exec confirmed as U.S. Health & Human Services secretary

by Andrea Widener
January 29, 2018 | APPEARED IN VOLUME 96, ISSUE 5

[+]Enlarge
Credit: Tom Williams/CQ Roll Call/Newscom
Azar speaks during his Senate confirmation hearing on Jan. 9.
Credit: Tom Williams/CQ Roll Call/Newscom
Azar speaks during his Senate confirmation hearing on Jan. 9.

Alex Azar, President Donald J. Trump’s nominee to head the U.S. Department of Health & Human Services (HHS), was confirmed by the Senate on Jan. 24. Azar is the former president of Lilly USA, the parent company of pharmaceutical giant Eli Lilly & Co., where he worked for 10 years before being nominated by Trump. HHS oversees most of the nation’s health care industry, including Medicare and the insurance program known as Obamacare. It also is the parent agency for the Food & Drug Administration, the Centers for Disease Control & Prevention, and the National Institutes of Health. Azar doesn’t have a science background—he is a lawyer with an undergraduate degree in economics and government. In his confirmation hearing, Azar said that drug prices are too high and he would explore whether the government should be able to negotiate lower fees. He previously served in HHS during the George W. Bush administration as deputy director and general counsel. Azar replaces Tom Price, Trump’s first appointee to the HHS position, who resigned in September 2017 over criticism of his use of private jets for government travel.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment